USP9X and neoplasm: On the oncogenic side, USP9X stabilizes critical anti-apoptotic proteins (such as MCL-1 and XIAP) through deubiquitination, thereby enhancing tumor cell survival and contributing to chemotherapy resistance, a mechanism observed in multiple malignancies.